| Go Pro | AZ1 Chatter | IMYO FYI | Tell your friends and family about NICHEY & AZ1 |

The SGLT2 inhibitors market continues to expand significantly, primarily due to the increasing prevalence of type 2 diabetes and the growing demand for effective therapies in managing cardiovascular and renal conditions